Remove Biobanking Remove Clinical Trials Remove Insulin
article thumbnail

Alnylam finds belly fat gene and drug target in UK Biobank study

pharmaphorum

The American Heart Association issued a statement last year highlighting the risks of visceral and abdominal fat (VAT), calling for clinical trials of therapies to reduce it, as well as greater efforts to encourage patients to exercise and improve their diets. Image by Bruno /Germany from Pixabay .